Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

3 Top Artificial Intelligence (AI) Stocks Ready for a Bull Runfool.com
Via The Motley Fool · April 28, 2025
Why Airbus Stock Popped Todayfool.com
Boeing or Airbus: Which one should you choose?
Via The Motley Fool · April 28, 2025
3 High-Yield Energy Stocks to Buy to Create Years of Passive Incomefool.com
Via The Motley Fool · April 28, 2025
Should Nvidia Investors Be Worried About Its Singapore Revenue?fool.com
Via The Motley Fool · April 28, 2025
Asian Stock: Hyundai Glovistalkmarkets.com
Via Talk Markets · April 28, 2025
What to Expect from Corning's Earningsbenzinga.com
Via Benzinga · April 28, 2025
Earnings Preview: Laboratory Corpbenzinga.com
Via Benzinga · April 28, 2025
SoFi Techs's Earnings: A Previewbenzinga.com
Via Benzinga · April 28, 2025
Nvidia and Broadcom Got Fantastic News From Googlefool.com
Alphabet reported strong demand for cloud and AI solutions.
Via The Motley Fool · April 28, 2025
Is British American Tobacco Stock a Long-Term Buy?fool.com
The stock emerged from a disastrous decade and could now outperform the market moving forward.
Via The Motley Fool · April 28, 2025
4 Brilliant Growth Stocks to Buy Now and Hold for the Long Termfool.com
Consider buying small stakes in these fundamentally strong stocks now.
Via The Motley Fool · April 28, 2025
Navigating A Roller Coaster Marketbenzinga.com
Trading the chaos--profitably.
Via Benzinga · April 28, 2025
Kraft Heinz's Earnings: A Previewbenzinga.com
Via Benzinga · April 28, 2025
Tesla's "Moment of Truth"fool.com
Tesla's net income decreased by 71% compared to a year ago. But Wall Street doesn't seem to mind.
Via The Motley Fool · April 28, 2025
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billionbenzinga.com
Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.
Via Benzinga · April 28, 2025
Saia's Q1 'Shocked Even The Bears': Analyst Slashes Price Target, Compares Fundamentals With Peersbenzinga.com
Saia reports worse-than-expected yields, leading to a price target cut by JPMorgan. Competition and contract renewals also impacted results.
Via Benzinga · April 28, 2025
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · April 28, 2025
CrowdStrike Launches New AI Tools To Strengthen Cybersecurity, Expand Threat Detectionbenzinga.com
CrowdStrike Holdings on Monday showcased Charlotte AI Agentic Response and Charlotte AI Agentic Workflows.
Via Benzinga · April 28, 2025
Ant Group's Alipay Hits 100 Million Users, Unveils New Chip To Power Fintech Expansionbenzinga.com
Alipay, Ant Group's mobile payment platform, reported 100M+ users for its tap-and-pay service. It introduced cashless society in China.
Via Benzinga · April 28, 2025
Why Viking Therapeutics Stock Popped Todayfool.com
2025 is the year we learn whether Viking Therapeutics stock will be a winner.
Via The Motley Fool · April 28, 2025
Palantir Stock Is Pulling Back After Rallying 20% Over The Past Week: What's Going On?benzinga.com
Palantir Technologies shares have soared 22% over the past week. The rally is fueled by a combination of favorable geopolitical developments, major defense partnerships and technical signals.
Via Benzinga · April 28, 2025
Sabre Divests Hospitality Arm To TPG For $1.1B, Plans Debt Reductionbenzinga.com
Sabre expects to receive approximately $960 million in net proceeds after taxes and fees once the deal wraps.
Via Benzinga · April 28, 2025
A Look at Logitech International's Upcoming Earnings Reportbenzinga.com
Via Benzinga · April 28, 2025
Stop Chasing Returns. Start Building Wealth.benzinga.com
Most people think building wealth is about continually pursuing the highest returns. Here's how compounding wealth actually works — and why most investors get it wrong.
Via Benzinga · April 28, 2025
Uncovering Potential: Ares Capital's Earnings Previewbenzinga.com
Via Benzinga · April 28, 2025